61 related articles for article (PubMed ID: 14735234)
1. Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT.
Bîrsan T; Dambrin C; Marsh KC; Jacobsen W; Djuric SW; Mollison KW; Christians U; Carter GW; Morris RE
Transpl Int; 2004 Mar; 17(3):145-50. PubMed ID: 14735234
[TBL] [Abstract][Full Text] [Related]
2. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro.
Bîrsan T; Dambrin C; Freitag DG; Yatscoff RW; Morris RE
Transpl Int; 2005 May; 17(12):767-71. PubMed ID: 15827754
[TBL] [Abstract][Full Text] [Related]
3. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
Flores MG; Zhang S; Ha A; Holm B; Reitz BA; Morris RE; Borie DC
J Immunol Methods; 2004 Jun; 289(1-2):123-35. PubMed ID: 15251418
[TBL] [Abstract][Full Text] [Related]
6. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors.
Giese T; Zeier M; Meuer S
Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv55-60. PubMed ID: 15240851
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells.
Aubareda A; Mulero MC; Pérez-Riba M
Cell Signal; 2006 Sep; 18(9):1430-8. PubMed ID: 16406492
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
Du MR; Zhou WH; Dong L; Zhu XY; He YY; Yang JY; Li DJ
Biol Reprod; 2008 Jun; 78(6):1102-10. PubMed ID: 18322274
[TBL] [Abstract][Full Text] [Related]
11. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression.
Venkatesh N; Feng Y; DeDecker B; Yacono P; Golan D; Mitchison T; McKeon F
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8969-74. PubMed ID: 15184684
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
Giese T; Zeier M; Schemmer P; Uhl W; Schoels M; Dengler T; Buechler M; Meuer S
Transplantation; 2004 Feb; 77(3):339-44. PubMed ID: 14966405
[TBL] [Abstract][Full Text] [Related]
13. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
[TBL] [Abstract][Full Text] [Related]
14. Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway.
Mazière C; Morlière P; Louandre C; Conte MA; Gomilla C; Santus R; Antonicelli F; Hornebeck W; Mazière JC
Free Radic Biol Med; 2005 Dec; 39(12):1629-37. PubMed ID: 16298688
[TBL] [Abstract][Full Text] [Related]
15. 3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator.
Djuric SW; BaMaung NY; Basha A; Liu H; Luly JR; Madar DJ; Sciotti RJ; Tu NP; Wagenaar FL; Wiedeman PE; Zhou X; Ballaron S; Bauch J; Chen YW; Chiou XG; Fey T; Gauvin D; Gubbins E; Hsieh GC; Marsh KC; Mollison KW; Pong M; Shaughnessy TK; Sheets MP; Smith M; Trevillyan JM; Warrior U; Wegner CD; Carter GW
J Med Chem; 2000 Aug; 43(16):2975-81. PubMed ID: 10956206
[TBL] [Abstract][Full Text] [Related]
16. The differential effect of Eriobotrya japonica hydrophilic leaf extract on cytokines production and modulation.
Matalka KZ; Ali D; Khawad AE; Qa'dan F
Cytokine; 2007 Dec; 40(3):235-40. PubMed ID: 18036829
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein elicits an intracellular calcium rise and increases the binding activity of the transcription factor NFAT.
Mazière C; Morlière P; Massy Z; Kamel S; Louandre C; Conte MA; Mazière JC
Free Radic Biol Med; 2005 Feb; 38(4):472-80. PubMed ID: 15649649
[TBL] [Abstract][Full Text] [Related]
18. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
Sommerer C; Morath C; Giese T; Meuer S; Zeier M
Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
Wong VK; Zhou H; Cheung SS; Li T; Liu L
J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
[TBL] [Abstract][Full Text] [Related]
20. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
